חוב כולל להון Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals (ATNM) bases its operations on New York-based radiopharmaceutical centers, while isotope synthesis is entrusted to specialized nuclear laboratories with enhanced security. This chart of the share price demonstrates the 0.04 metric. The business relies on external contractors for clinical trials, manufacturing, and global logistics to maintain a maximum focus on discovering blood cancer therapies.

Developing a targeted radiotherapy ecosystem for hematology requires significant investment, making financial leverage control critically important. By analyzing the debt-to-equity ratio, an investor assesses the proportion of borrowed capital within the balance sheet structure, where a decrease in this metric confirms the high autonomy and stability of Actinium Pharmaceuticals (ATNM) market value in the face of debt risks.